Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Lixte Biotechnology Holdings, Inc. per 2025 Jun 30 adalah -3.08 MM.
- Nilai net income untuk Lixte Biotechnology Holdings, Inc. per 2025 Jun 30 adalah -3.09 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -3.08 | -3.09 | |
2025-03-31 | -3.31 | -3.32 | |
2024-12-31 | -3.57 | -3.59 | |
2024-09-30 | -3.99 | -4.00 | |
2024-06-30 | -4.03 | -4.03 | |
2024-03-31 | -4.69 | -4.69 | |
2023-12-31 | -5.09 | -5.09 | |
2023-09-30 | -5.70 | -5.69 | |
2023-06-30 | -6.15 | -6.15 | |
2023-03-31 | -6.03 | -6.02 | |
2022-12-31 | -6.31 | -6.31 | |
2022-09-30 | -6.70 | -6.71 | |
2022-06-30 | -6.46 | -6.47 | |
2022-03-31 | -6.65 | -6.66 | |
2021-12-31 | -6.72 | -6.73 | |
2021-09-30 | -5.60 | -5.61 | |
2021-06-30 | -5.96 | -5.97 | |
2021-03-31 | -4.60 | -4.61 | |
2020-12-31 | -3.27 | -3.26 | |
2020-09-30 | -2.69 | -2.68 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | -1.44 | -1.44 |
2024-12-31 | -1.59 | |
2024-09-30 | -1.78 | -1.78 |
2024-06-30 | -1.83 | -1.83 |
2024-03-31 | -2.27 | -2.28 |
2023-12-31 | -2.66 | |
2023-09-30 | -3.21 | -3.21 |
2023-06-30 | -3.69 | -3.69 |
2023-03-31 | -3.64 | -3.64 |
2022-12-31 | -3.99 | -3.99 |
2022-09-30 | -4.45 | -4.45 |
2022-06-30 | -4.51 | -4.51 |
2022-03-31 | -4.85 | -4.85 |
2021-12-31 | -4.99 | |
2021-09-30 | -4.33 | -4.33 |
2021-06-30 | -4.86 | -4.86 |
2021-03-31 | -3.95 | -3.95 |
2020-12-31 | -2.90 | |
2020-09-30 | -2.40 | -2.40 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Lixte Biotechnology Holdings, Inc. per 2025 Jun 30 adalah -2.61 MM.
- Nilai kas dari aktivitas pendanaan untuk Lixte Biotechnology Holdings, Inc. per 2025 Jun 30 adalah 0.90 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -2.61 | 0.90 | |
2025-03-31 | -2.94 | 0.91 | |
2024-12-31 | -3.16 | ||
2024-09-30 | -3.47 | 0.00 | |
2024-06-30 | -3.45 | 3.14 | |
2024-03-31 | -3.81 | 3.14 | |
2023-12-31 | -4.29 | 3.14 | |
2023-09-30 | -4.60 | 3.14 | |
2023-06-30 | -4.83 | 0.01 | |
2023-03-31 | -4.85 | 5.16 | |
2022-12-31 | -4.61 | 5.14 | |
2022-09-30 | -4.55 | 5.15 | |
2022-06-30 | -4.30 | 5.24 | |
2022-03-31 | -4.15 | 0.19 | |
2021-12-31 | -4.14 | 3.90 | |
2021-09-30 | -3.74 | 8.62 | |
2021-06-30 | -3.43 | 8.46 | |
2021-03-31 | -2.74 | 8.30 | |
2020-12-31 | -2.13 | 4.60 | |
2020-09-30 | -1.77 | -0.13 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk Lixte Biotechnology Holdings, Inc. pada 2025 Jun 30 adalah 2.10.
- p/tbv untuk Lixte Biotechnology Holdings, Inc. pada 2025 Jun 30 adalah -1.04.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 2.10 | -1.04 | |
2025-03-31 | -0.95 | 4.12 | 4.12 |
2024-12-31 | 3.14 | 3.14 | |
2024-09-30 | -1.09 | 1.96 | 1.96 |
2024-06-30 | -1.14 | 1.71 | 1.71 |
2024-03-31 | -1.56 | 1.98 | 1.98 |
2023-12-31 | -0.93 | 1.07 | 1.07 |
2023-09-30 | -0.90 | 2.05 | 2.05 |
2023-06-30 | -16.21 | 23.92 | 23.92 |
2023-03-31 | -2.18 | 2.67 | |
2022-12-31 | 1.32 | 1.32 | |
2022-09-30 | 1.25 | 1.25 | |
2022-06-30 | -1.86 | 3.57 | 3.57 |
2022-03-31 | -2.51 | 3.53 | 3.53 |
2021-12-31 | -2.89 | 2.67 | 2.67 |
2021-09-30 | -4.79 | 4.16 | 4.16 |
2021-06-30 | |||
2021-03-31 | -3.52 | 2.12 | 2.12 |
2020-12-31 | -4.56 | 2.97 | 2.97 |
2020-09-30 | -5.00 | 11.75 | 11.75 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Lixte Biotechnology Holdings, Inc. pada 2025 Jun 30 adalah -0.73.
- EBIT (3 tahun) / EV untuk Lixte Biotechnology Holdings, Inc. pada 2025 Jun 30 adalah -0.99.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.73 | -0.99 |
2025-03-31 | -0.61 | -0.81 |
2024-12-31 | -0.65 | -0.83 |
2024-09-30 | -0.76 | -1.03 |
2024-06-30 | -0.87 | -1.07 |
2024-03-31 | -0.71 | -0.84 |
2023-12-31 | -1.55 | -1.63 |
2023-09-30 | -1.01 | -1.02 |
2023-06-30 | -0.06 | -0.06 |
2023-03-31 | -0.53 | -0.49 |
2022-12-31 | -1.24 | -0.92 |
2022-09-30 | -1.27 | -0.97 |
2022-06-30 | -0.55 | -0.41 |
2022-03-31 | -0.43 | -0.29 |
2021-12-31 | -0.41 | -0.27 |
2021-09-30 | -0.24 | -0.15 |
2021-06-30 | ||
2021-03-31 | -0.38 | -0.26 |
2020-12-31 | -0.25 | -0.20 |
2020-09-30 | -0.17 | -0.16 |
Efektivitas Manajemen
- roa untuk Lixte Biotechnology Holdings, Inc. pada 2025 Jun 30 adalah -1.25.
- roe untuk Lixte Biotechnology Holdings, Inc. pada 2025 Jun 30 adalah -1.48.
- roic untuk Lixte Biotechnology Holdings, Inc. pada 2025 Jun 30 adalah -2.87.
- croic untuk Lixte Biotechnology Holdings, Inc. pada 2025 Jun 30 adalah -1.75.
- ocroic untuk Lixte Biotechnology Holdings, Inc. pada 2025 Jun 30 adalah -2.54.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -1.25 | -1.48 | -2.87 | -1.75 | -2.54 |
2025-03-31 | -1.00 | -1.15 | -4.33 | -3.83 | -3.83 |
2024-12-31 | -0.93 | -1.00 | -2.93 | -2.54 | -2.54 |
2024-09-30 | -0.77 | -0.82 | -1.80 | -0.14 | -1.54 |
2024-06-30 | -1.08 | -1.15 | -1.50 | -0.22 | -1.22 |
2024-03-31 | -0.91 | -0.98 | -1.27 | -0.29 | -1.07 |
2023-12-31 | -0.83 | -0.89 | -1.16 | -0.30 | -0.93 |
2023-09-30 | -0.77 | -0.82 | -2.28 | -1.79 | -1.79 |
2023-06-30 | -0.75 | -0.80 | -2.28 | -1.79 | -1.79 |
2023-03-31 | -1.53 | -1.82 | -1.48 | 0.08 | -1.19 |
2022-12-31 | -1.06 | -1.10 | -1.05 | 0.09 | -0.71 |
2022-09-30 | -1.02 | -1.07 | -1.05 | 0.09 | -0.71 |
2022-06-30 | -0.92 | -0.97 | -0.86 | 0.13 | -0.57 |
2022-03-31 | -0.85 | -0.88 | -1.92 | -1.14 | -1.20 |
2021-12-31 | -1.07 | -1.12 | -1.40 | -0.05 | -0.61 |
2021-09-30 | -4.11 | -5.23 | -0.92 | 0.80 | -0.50 |
2021-06-30 | -3.16 | -3.56 | -0.87 | 0.73 | -0.50 |
2021-03-31 | -2.02 | -2.25 | -0.60 | 0.73 | -0.36 |
2020-12-31 | -1.22 | -1.34 | -0.65 | 0.49 | -0.43 |
2020-09-30 | -0.87 | -0.97 | -2.35 | -1.67 | -1.55 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1335105 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |